☆ 4.5 Article

Initial statin dose after myocardial infarction and long-term cardiovascular outcomes

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, General & Internal

Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction The PACMAN-AMI Randomized Clinical Trial

Lorenz Raber et al.

Summary: Among patients with acute myocardial infarction, the addition of biweekly subcutaneous alirocumab to high-intensity statin therapy resulted in significantly greater regression of coronary plaques in non-infarct-related arteries after 52 weeks. Further research is needed to understand whether alirocumab improves clinical outcomes in this population.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Less revascularization in young women but impaired long-term outcomes in young men after myocardial infarction

Anne M. Kerola et al.

Summary: Compared to young men, young women receive less treatment after myocardial infarction, but after adjusting for baseline features, male patients have poorer cardiovascular outcomes.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Early statin use and cardiovascular outcomes after myocardial infarction: A population-based case-control study

Ville Kyto et al.

Summary: This study found that not using statins early after myocardial infarction (MI) is associated with adverse outcomes, including higher all-cause mortality and incidence of cardiovascular events. The lack of statin therapy was associated with increased risk for patients, regardless of other factors such as gender, age, comorbidities, etc.

ATHEROSCLEROSIS (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Case Fetality of Patients With Type 1 Diabetes After Myocardial Infarction

Anne M. Kerola et al.

Summary: This study found that patients with type 1 diabetes have a higher case fatality rate after myocardial infarction compared to patients without diabetes. Younger age, heart failure, peripheral vascular disease, and no revascularization were associated with the highest risk.

DIABETES CARE (2022)

添加到收藏夹

Article Clinical Neurology

Impact of Oral Anticoagulation and Adenosine Diphosphate Inhibitor Therapies on Short-term Outcome of Traumatic Brain Injury

Jussi P. Posti et al.

Summary: This study investigates the impact of oral anticoagulant (OAC) and adenosine diphosphate inhibitor (ADPi) therapies on short-term outcomes after traumatic brain injury (TBI). The results show that patients using vitamin K antagonists (VKA) have a higher case-fatality rate compared to patients without OAC. However, patients using direct OACs (DOAC) have lower case-fatality rates, and ADPi is not associated with the outcomes studied.

NEUROLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Intensity of and Adherence to Lipid-Lowering Therapy as Predictors of Major Adverse Cardiovascular Outcomes in Patients With Coronary Heart Disease

Faizan Mazhar et al.

Summary: This study evaluated the associations of lipid-lowering therapy (LLT) intensity, adherence, and their combination with the risk of major adverse cardiovascular events (MACE) in patients with coronary heart disease. The results showed that higher LLT adherence and intensity were associated with a lower risk of MACE and higher odds of achieving low-density lipoprotein cholesterol goals. Strategies to improve adherence and use of intensive therapies could significantly reduce cardiovascular risk in these patients.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cardiovascular event rates increase after each recurrence and associate with poor statin adherence

Mariann Lassenius et al.

Summary: The study evaluated the quality of cardiovascular prevention by assessing the recurrence of up to five cardiovascular events and investigating low-density lipoprotein cholesterol concentrations and lipid-lowering therapy use. The results showed a wide interindividual variation in cardiovascular event recurrence, with each additional event increasing the risk and the median time of recurrence decreasing. Underuse of statins and poor adherence were associated with increased risk of recurrence, highlighting the need for intensified preventive measures in these patients.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Jean-Philippe Collet et al.

EUROPEAN HEART JOURNAL (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Adherence to recommendations for secondary prevention medications after myocardial infarction in Estonia: comparison of real-world data from 2004 to 2005 and 2017 to 2018

Piret Loiveke et al.

Summary: Adherence to guideline-recommended medications for secondary prevention of myocardial infarction has improved in Estonia, but there is still room for enhancement, emphasizing the need for systematic guideline implementation and increased attention to secondary prevention of MI.

BMC CARDIOVASCULAR DISORDERS (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study

Jessica Schubert et al.

Summary: Clinical trials have shown that reducing LDL-C can decrease cardiovascular events, and a study found that larger reductions in LDL-C and more intensive statin therapy after myocardial infarction were associated with lower risks of cardiovascular outcomes and all-cause mortality.

EUROPEAN HEART JOURNAL (2021)

添加到收藏夹

Article Medicine, General & Internal

Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study

M. Casula et al.

Summary: The PROSISA study found that 9.6% of dyslipidaemic patients reported statin-associated muscle symptoms (SAMS), with only one third of patients still reporting SAMS after dechallenge/rechallenge.

JOURNAL OF INTERNAL MEDICINE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Clinical impact and room for improvement of intensity and adherence to lipid lowering therapy: Five years of clinical follow-up from 164,565 post-myocardial infarction patients

Francois Schiele et al.

Summary: The study found that high-intensity LLT prescriptions were limited and adherence to LLT was low among patients with a history of myocardial infarction. Higher treatment intensity, adherence, and adherence-adjusted intensity were all associated with a significantly lower risk of major adverse cardiovascular events.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)

Frank L. J. Visseren et al.

EUROPEAN HEART JOURNAL (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

Francois Mach et al.

EUROPEAN HEART JOURNAL (2020)

添加到收藏夹

Article Medicine, General & Internal

Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016

Xiaoxi Yao et al.

JAMA NETWORK OPEN (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Long-term Outcomes of Mechanical Vs Biologic Aortic Valve Prosthesis in Patients Older Than 70 Years

Ville Kyto et al.

ANNALS OF THORACIC SURGERY (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

Guy De Backer et al.

ATHEROSCLEROSIS (2019)

添加到收藏夹

Article Hematology

Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association

Connie B. Newman et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)

Borja Ibanez et al.

EUROPEAN HEART JOURNAL (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Lipid Testing and Statin Dosing After Acute Myocardial Infarction

William T. Wang et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)

添加到收藏夹

Article Medicine, General & Internal

Sensitivity Analysis in Observational Research: Introducing the E-Value

Tyler J. VanderWeele et al.

ANNALS OF INTERNAL MEDICINE (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Introduction to the Analysis of Survival Data in the Presence of Competing Risks

Peter C. Austin et al.

CIRCULATION (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction

Supriya Shore et al.

HEART (2015)

添加到收藏夹

Article Medicine, General & Internal

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

Jordan Fulcher et al.

LANCET (2015)

添加到收藏夹

Article Medicine, General & Internal

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

Christopher P. Cannon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

添加到收藏夹

Article Public, Environmental & Occupational Health

Forty-year trends in cardiovascular risk factors in Finland

Katja Borodulin et al.

EUROPEAN JOURNAL OF PUBLIC HEALTH (2015)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Neil J. Stone et al.

CIRCULATION (2014)

添加到收藏夹

Review Pharmacology & Pharmacy

Phenotype Standardization for Statin-Induced Myotoxicity

A. Alfirevic et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)

添加到收藏夹

Letter Pharmacology & Pharmacy

Measurement of statin exposure in the absence of information on prescribed doses

Tomi Romppainen et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Effect of Statins on Skeletal Muscle Function

Beth A. Parker et al.

CIRCULATION (2013)

添加到收藏夹

Article Medicine, General & Internal

Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial

R. Bulbulia et al.

LANCET (2011)

添加到收藏夹

Article Medicine, General & Internal

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

C. Baigent et al.

LANCET (2010)

添加到收藏夹

Article Health Care Sciences & Services

Impact of Restricted Reimbursement on the Use of Statins in Finland A Register-Based Study

Jaana E. Martikainen et al.

MEDICAL CARE (2010)

添加到收藏夹

Article Medicine, General & Internal

Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis

LANCET (2008)

添加到收藏夹

Article Medicine, General & Internal

Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction

Jeppe N. Rasmussen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients -: The PRIMO study

E Bruckert et al.

CARDIOVASCULAR DRUGS AND THERAPY (2005)

添加到收藏夹

Article Medicine, General & Internal

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

CP Cannon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.